On 10/30/13, UBS Preferred Funding Trust IV Floating Rate Non-Cumulative Trust Preferred Securities (UBS.PRD) will trade ex-dividend, for its monthly dividend of $0.0188, payable on 11/15/13. As a percentage of UBS.PRD's recent share price of $14.85, this dividend works out to approximately 0.13%. On an annualized basis, the current yield is approximately 1.52%, which compares to an average yield of 5.95% in the "Financial" preferred stock category, according to Preferred Stock Channel.As of last close, UBS.PRD was trading at a 40.44% discount to its liquidation preference amount. Investors should keep in mind that the shares are not cumulative, meaning that in the event of a missed payment, the company does not have to pay the balance of missed dividends to preferred shareholders before resuming a common dividend.The chart below shows the one year performance of UBS.PRD shares, versus UBS: Below is a dividend history chart for UBS.PRD, showing historical dividends prior to the most recent $0.0188 on UBS Preferred Funding Trust IV Floating Rate Non-Cumulative Trust Preferred Securities: According to the ETF Finder at ETF Channel, UBS AG ( UBS - Get Report) makes up 4.30% of the Bank and Brokerage ETF (RKH) which is trading relatively unchanged on the day Monday. In Monday trading, UBS Preferred Funding Trust IV Floating Rate Non-Cumulative Trust Preferred Securities ( UBS.PRD) is currently off about 0.3% on the day, while the common shares ( UBS - Get Report) are up about 0.7%.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Beyond Meat Sizzles Following Launch of 'Beyond Beef' Product
Beyond Meat's new plant-based ground meat is made without GMOs, soy or gluten.
Micron's Unexpected Move Higher Boosts Semiconductor Sentiment
Micron is motivating more positive outlook on the semiconductor sector's road ahead.
AbbVie's Allergan Deal Sets Up Another Trade In Big Biotech
The drop in AbbVie's stock price following revelation of its plans to buy Allergan provides a way to hit a solid investment single using a buy-write options strategy.
Micron Looks Higher for the Open but the Charts Could Use More Strength
Let's check the charts this morning ahead of the open, imagining strength to the $35.50 area.